Udenyca (Biosimilar to Neulasta) Now Approved Page

Nov 14, 2018Nov 13, 2018

Brand: Udenyca (pegfilgrastim-cbqv), Injection
Parent Company: Coherus
Drug Type: Prescription
Drug Category: Oncology
Campaign: now-approved
Targeting: HCPs
Patient Website: http://www.udenyca.com/
HCP Website:

: Home

: Home – Animation 1

: Home – Animation 2

: Mobile View

The gallery of digital pharma marketing screenshots.

Udenyca (Biosimilar to Neulasta) Now Approved Page

Your Email

Name
This field is for validation purposes and should be left unchanged.

We’ll never share or sell your personal info. Ever.